NCT05544487

Brief Summary

Colorectal resection due to benign and malignant diseases is a commonly performed procedure. The continuity of the gastrointestinal tract is re-established by creating an anastomosis. Although such procedures are often performed, anastomotic techniques and postoperative outcomes usually vary. Failure of the anastomosis might be a life-threatening condition after colorectal resection. A relatively high incidence of anastomotic leaks (up to 30%) has been reported worldwide. Anastomotic failure could happen due to several reasons, that are divided into surgeon-related factors and patient-related factors. So far, there has been no data about the incidence of anastomotic leak in the Western Balkans and the Mediterranean countries.The aim of EAST-WEST Colorectal Study 2022 is to investigate differences in patients undergoing colorectal resections, including pre-operative patient preparation, history of prior surgeries and anastomotic techniques. In addition, this study aims to collect data about post-operative complication rate within 30 days post-surgery across Balkan countries (Slovenia, Serbia, Macedonia, Croatia, BIH and Monte Negro), Greece, Romania and Malta, hence the study outcomes could be applicable to the Mediterranean region, in which patients share a common set of characteristics. This would enable variabilities in practice to be identified and differences regarding postoperative outcomes to be highlighted.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2022

Shorter than P25 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 10, 2022

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 16, 2022

Completed
15 days until next milestone

Study Start

First participant enrolled

October 1, 2022

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2023

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2023

Completed
Last Updated

October 10, 2022

Status Verified

October 1, 2022

Enrollment Period

4 months

First QC Date

September 10, 2022

Last Update Submit

October 7, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Leakage rate

    30 days

Secondary Outcomes (5)

  • Re-admission rate within the first 30 days post-surgery.

    30 days

  • 30-day postoperative morbidity

    30 days

  • 30-day postoperative mortality

    30 days

  • Clavien-Dindo complication classification

    30 days

  • Length of stay

    30 days

Interventions

Differences in intra-operative techniques and surgeon grades

Eligibility Criteria

AgeUp to 90 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patients undergoing colorectal anastomoses due to benign or malignant reasons.

You may qualify if:

  • Adults between 18-90 years old undergoing colorectal resection with anastomosis due to benign and malignant diseases
  • Any of the procedures listed below performed as an emergency or elective surgery, and by any approach; open, laparoscopic or robotic:
  • Right hemicolectomy and extended right hemicolectomy
  • Ileocecal resection
  • Transverse colon resection
  • Segmental colonic resection - i.e. splenic resection
  • Left hemicolectomy
  • Sigmoid resection
  • Rectal resection
  • Pan-proctocolectomy

You may not qualify if:

  • Closure of ileostomy or colostomy
  • Creation of multiple anastomoses
  • Small bowel resection
  • Pelvic exenteration
  • Cytoreductive surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Central Study Contacts

Maximos Frountzas, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Target Duration
30 Days
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Surgery

Study Record Dates

First Submitted

September 10, 2022

First Posted

September 16, 2022

Study Start

October 1, 2022

Primary Completion

February 1, 2023

Study Completion

June 1, 2023

Last Updated

October 10, 2022

Record last verified: 2022-10